论文部分内容阅读
目的探讨针对急性脑梗死患者应用奥扎格雷联合血塞通治疗的临床效果。方法选取我院2013年3月-2014年3月收治的76例急性脑梗死患者作为研究样本,随机分为观察组与对照组各38例,两组患者均采用奥扎格雷药物治疗,观察组增加血塞通联合治疗。结果观察组样本治疗后的总有效率为92.1%,对照组样本治疗后的总有效率为79.0%,组间比较存在显著差异,具有统计学意义(P<0.05)。结论针对急性脑梗死患者应用奥扎格雷联合血塞通治疗,能够有效增加脑部供血总量,缓解神经功能缺损程度,具有确切的应用价值。
Objective To investigate the clinical effect of ozagrel combined with Xuesaitong in the treatment of acute cerebral infarction. Methods Seventy-six patients with acute cerebral infarction who were treated in our hospital from March 2013 to March 2014 were randomly divided into observation group (38 cases) and control group (38 cases). Ozagrel was used in both groups. The observation group Increase Xuesaitong combination therapy. Results The total effective rate of the observation group after treatment was 92.1%, while the total effective rate of the control group after treatment was 79.0%. There was significant difference between the two groups (P <0.05). Conclusion The application of ozagrel in combination with Xuesaitong in patients with acute cerebral infarction can effectively increase the total amount of blood supply to the brain and relieve the degree of neurological deficits, which has the exact value of application.